# Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

> **NCT01347073** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 23 (actual)

## Conditions studied

- Urea Cycle Disorders

## Interventions

- **DRUG:** HPN-100

## Key facts

- **NCT ID:** NCT01347073
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347073, "Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01347073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*